Danaher | DHR - Créances Commerciales

Prix De L'Action
178.80
Variation Quotidienne
-0.18 -0.10%
Mensuellement
-2.77%
Annuel
-10.30%
Q2 Prévisions
173.46




Créances Commerciales Changement Date
Abbott USD 10.57B 171M 2025-12
Agilent USD 1.52B 34M 2025-12
Align Technology USD 1.13B 23.36M 2026-03
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Bio Techne USD 184.61M 717K 2025-12
Bio-Rad Laboratories USD 464.7M 5.2M 2025-09
Boston Scientific USD 2.93B 98M 2025-12
Bruker USD 544.9M 6M 2025-12
Charles River Laboratories USD 1.43B 54.59M 2025-12
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 688M 34M 2025-12
Edwards Lifesciences USD 912.1M 19.3M 2025-12
ESCO Technologies USD 333.99M 10.29M 2025-12
Fortive USD 683.6M 50M 2025-12
Henry Schein USD 1.65B 92M 2025-12
Illumina USD 854M 125M 2025-12
Intuitive Surgical USD 1.6B 68.3M 2026-03
IQVIA Holdings USD 3.43B 113M 2025-12
Keysight Technologies USD 914M 25M 2025-12
Laboratory Of America USD 2.26B 4.5M 2025-12
Medtronic USD 6.36B 30M 2025-12
Mettler Toledo International USD 778.24M 90.98M 2025-12
Myriad Genetics USD 115.3M 2.7M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Quest Diagnostics USD 1.59B 179M 2026-03
Quidel USD 417M 30.5M 2025-12
Repligen USD 158.59M 9.62M 2025-12
Revvity USD 744.67M 64.41M 2025-12
Roper Industries USD 1.11B 144.9M 2026-03
Stryker USD 4.04B 396M 2025-12
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Waters USD 828.84M 80.32M 2025-12
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03